FDA adds boxed warning to multiple sclerosis drugs

The menopausal transition may represent an inflection point for worsening of multiple sclerosis (MS) in women, accordi ...
A recent study shows that menopause may worsen Multiple Sclerosis symptoms and accelerate its progression due to a decline in ...
A new study reveals that people with multiple sclerosis (MS) experience significantly higher rates of mental illness during ...
People with multiple sclerosis (MS) face a significantly higher risk of perinatal mental illness compared to those with other ...
Researchers at the University of Colorado Anschutz Medical Campus have found a promising drug candidate that could help ...
Researchers at the University of Colorado Anschutz Medical Campus have identified LL-341070, a promising drug candidate that ...
Researchers at the University of Colorado Anschutz Medical Campus have found a promising drug candidate that could help ...
The study identified gene expression changes which were detected beginning three months after intranasal dosing of foralumab in our ongoing ISPPEA (or expanded access program). Key findings include ...
MS patients who achieve long-term stable disease on disease-modifying therapy may want to stop their medication for varying ...